Aberrant expression and prognostic potential of IL-37 in human lung adenocarcinoma

Christodoulou, P., Kyriakou, T.-C., Boutsikos, P., Andreou, M., Ji, Y., Xu, D., Papageorgis, P. and Christodoulou, M.-I. (2022) Aberrant expression and prognostic potential of IL-37 in human lung adenocarcinoma. Biomedicines, 10(12), 3037. (doi: 10.3390/biomedicines10123037)

Abstract

Interleukin-37 (IL-37) is a relatively new IL-1 family cytokine that, due to its immunoregulatory properties, has lately gained increasing attention in basic and translational biomedical research. Emerging evidence supports the implication of this protein in any human disorder in which immune homeostasis is compromised, including cancer. The aim of this study was to explore the prognostic and/or diagnostic potential of IL-37 and its receptor SIGIRR (single immunoglobulin IL-1-related receptor) in human tumors. We utilized a series of bioinformatics tools and -omics datasets to unravel possible associations of IL-37 and SIGIRR expression levels and genetic aberrations with tumor development, histopathological parameters, distribution of tumor-infiltrating immune cells, and survival rates of patients. Our data revealed that amongst the 17 human malignancies investigated, IL-37 exhibits higher expression levels in tumors of lung adenocarcinoma (LUAD). Moreover, the expression profiles of IL-37 and SIGIRR are associated with LUAD development and tumor stage, whereas their high mRNA levels are favorable prognostic factors for the overall survival of patients. What is more, IL-37 correlates positively with a LUAD-associated transcriptomic signature, and its nucleotide changes and expression levels are linked with distinct infiltration patterns of certain cell subsets known to control LUAD anti-tumor immune responses. Our data indicate the potential value of IL-37 and its receptor SIGIRR to serve as biomarkers and/or immune-checkpoint therapeutic targets for LUAD patients. Further, the data highlight the urgent need for further exploration of this cytokine and the underlying pathogenetic mechanisms to fully elucidate its implication in LUAD development and progression.

• Item Type: Articles
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: Christodoulou, Dr Maria-Ioanna and Xu, Dr Damo and Ji, Mr Yuan
• Authors: Christodoulou, P., Kyriakou, T.-C., Boutsikos, P., Andreou, M., Ji, Y., Xu, D., Papageorgis, P., and Christodoulou, M.-I.
• College/School: College of Medical Veterinary and Life Sciences > School of Infection & Immunity
• Journal Name: Biomedicines
• Publisher: MDPI
• ISSN: 2227-9059
• ISSN (Online): 2227-9059
• Published Online: 24 November 2022
• Copyright Holders: Copyright © 2022 The Authors
• First Published: First published in Biomedicines 10(12): 3037
• Publisher Policy: Reproduced under a Creative Commons License